(RTTNews) – Nektar Therapeutics (NKTR) announced Friday the promotion of Jillian Thomsen to Senior Vice President (SVP) & Main Money Officer. Thomsen has served as SVP, Finance & Main Accounting Officer of Nektar because 2008, and is a key member of the Government Committee.
Gil Labrucherie, the firm’s present-day Main Operating Officer & Chief Fiscal Officer, will be departing the enterprise to pursue yet another opportunity at a non-public biotechnology company.
In April 2008, Thomsen was appointed Chief Accounting Officer at Nektar and joined the Govt Committee. She has about 30 several years of finance and accounting practical experience.
In her latest role, Thomsen oversees accounting, monetary reporting, FP&A, Sarbanes-Oxley compliance, treasury, tax, scientific outsourcing, and procurement functions at the business. From 2006 to 2008, she served as Vice President, Finance and Controller of Nektar.
Prior to becoming a member of Nektar in 2006, Thomsen was Deputy Controller of Calpine Corp. from September 2002 to February 2006.
The sights and thoughts expressed herein are the sights and thoughts of the creator and do not automatically replicate those of Nasdaq, Inc.